Chronic GIPR agonism results in pancreatic islet GIPR functional desensitisation
Open Access
- 7 January 2025
- journal article
- Published by Elsevier in Molecular Metabolism
- Vol. 92, 102094
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research Imperial Biomedical Research Centre
- Novo Nordisk Foundation
- UK Research and Innovation Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Wellcome Trust
- Eli Lilly and Company
This publication has 34 references indexed in Scilit:
- Regulation of energy metabolism through central GIPR signalingPeptides, 2024
- GLP-1 and GIP receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell functionCell Reports, 2023
- Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systemsMolecular Metabolism, 2022
- The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signalingCell Metabolism, 2021
- Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food IntakeCell Metabolism, 2019
- Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonismMolecular Metabolism, 2019
- Human GIP(3-30)NH2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptorsBiochemical Pharmacology, 2018
- Interrogating the Spatiotemporal Landscape of Neuromodulatory GPCR Signaling by Real-Time Imaging of cAMP in Intact Neurons and CircuitsCell Reports, 2018
- Central administration of GLP-1 and GIP decreases feeding in miceBiochemical and Biophysical Research Communications, 2017
- Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse isletsDiabetologia, 2016